News
A Phase 1 clinical trial has shown that an antibody developed at Stanford Medicine can prepare patients for stem cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback